ARA-290 (Cibinetide)Tissue RepairSafety Rating 7/10
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Price Comparison
Compare vendors · per 10mg
| Vendor | Price | $ / mg | Updated | |
|---|---|---|---|---|
| Ascension PeptidesBest $/mgCOA ✓ · 3P | $29.00 | $2.90 | Apr 16, 2026 | Buy → |
| Evolve PeptidesCOA ✓ · 3POut of stock | $42.50 | $3.54 | Apr 22, 2026 | Buy → |
| BioLongevity LabsCOA ✓ · 3P | $57.00 | $3.80 | Apr 16, 2026 | Buy → |
| SomaChemsCOA ✓ · 3P | $39.99 | $4.00 | May 14, 2026 | Buy → |
| Pinnacle Peptide LabsCOA on request | $42.49 | $4.25 | Apr 23, 2026 | Buy → |
Overview
About ARA-290
Mechanism of action
Non-erythropoietic EPO peptide analogue; selectively activates innate repair receptor (IRR); potent anti-inflammatory; neuroprotective; promotes tissue repair without erythropoietic effects of EPO.
Safety profile
Generally well-tolerated. Injection site reactions. No polycythemia (no red blood cell stimulation). Headache, fatigue in some subjects. · Phase II trials show good tolerability; no serious adverse events reported; innate repair receptor agonist
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops ARA-290 below your target.
Related pages